Once-daily aminoglycoside dosing: Impact on requests and costs for therapeutic drug monitoring

Therapeutic Drug Monitoring

Volumn 18, Issue 3, 1996, Pages 263-266

  Nicolau, David P ^a   Wu, Alan H B ^a   Finocchiaro, Sebastian ^a   Udeh, Elizabeth ^a   Chow, Moses S S ^a   Quintiliani, Richard ^a   Nightingale, Charles H ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

Cost effectiveness; Managed care; Nephrotoxicity; Once daily aminoglycoside; Therapeutic drug monitoring

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; TOBRAMYCIN;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG MONITORING; GRAM NEGATIVE INFECTION; HUMAN; NEPHROTOXICITY; PRIORITY JOURNAL; REIMBURSEMENT;

ADULT; ANTI-BACTERIAL AGENTS; DRUG MONITORING; GENTAMICINS; HUMANS; RETROSPECTIVE STUDIES; TOBRAMYCIN;

EID: 0029895354     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199606000-00007     Document Type: Article

References (9)

1. Zaske DE, Shikuma LR, Tholl DA. Aminoglycosides. In: A textbook for the clinical application of therapeutic drug monitoring. Irving, TX: Abbott Laboratories, 1986:285-320.
2. Gilbert DN. Once-daily aminoglycoside therapy. Antimicrob Agents Chemother 1991;35:399-405.
3. Verpooten GA, Giuliano RA, Verbist L, Eestermans G, DeBroe ME. Once-daily dosing decreases renal accumulation of gentamicin and netilmicin. Clin Pharmacol Ther 1989;45:22-7.
4. DeBroe ME, Verbist L, Verpooten GA. Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man. J Antimicrob Chemother 1991;27(suppl C):41-7.
5. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross J, Quintiliani R. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 1995;39:650-5.
6. Nicolau DP, Quintiliani R, Nightingale CH. Once-daily aminoglycosides. Conn Med 1992;56:561-3.
7. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
8. Smith CR, Lipsky JJ, Laskin OL, et al. Double blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 1980;302:1106-9.
9. Wu AHB. Therapeutic drug monitoring for the 1990s: meeting the laboratory needs of a changing environment. Wien Klin Wochenschr 1992;104(suppl 191):19-22.